Here's why Mehul Kothari is bullish on Glenmark Pharma, Muthoot Finance

According to the technical analyst from Anand Rathi, Glenmark Pharma can surge to Rs 460, while Muthoot Finance can rally to Rs 1,175.

technicals
technicals
Mehul Kothari Mumbai
2 min read Last Updated : Nov 09 2022 | 8:42 AM IST
BUY
Glenmark
Target: Rs 460
Stop Loss: Rs 405

Glenmark Pharma has observed a steep fall of 49 per cent between July 2021 and June 2022. Since then the stock has been consolidating between Rs 360-400, and it has made a solid base near Rs 375 level.

On the weekly scale, the said counter has formed an Inverted Bullish Hammer near support zone along with weekly RSI (relative strength index) has formed an impulsive structure which is adding more confirmation for upside in coming days.

Also Read


In line with above technical rationale Glenmark has broken its previous trading range of Rs 370-410 and closed well above it on weekly scale.

BUY
Muthoot Finance
Target: Rs 1,175
Stop Loss: Rs 1,085

After the free fall started from November 2021 till June 2022 which resulted in a 43 per cent decline in price. On a weekly scale the counter has formed a bullish shark with potential reversal zone (PRZ) of Rs 960-990 along with double bottom near mentioned PRZ which is adding more confirmation for early reversal in said counter.

From indicator perspective, Weekly RSI (relative strength index) has formed a complex structure along with the MACD bullish cross which further confirms upside for the stock.

(Mehul Kothari - AVP – Technical Research, Anand Rathi Shares & Stock Brokers. Views are personal).

 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Glenmark PharmaceuticalsMuthoot FinanceBuzzing stocksMarket technicalsstock market tradingStocks to buystocks technical analysistechnical chartsTrading strategies

Next Story